Skin reactions associated with bisphosphonates: a report of 3 cases and an approach to management. Phillips E, Knowles S, Weber E, Shear NH (1998) J Allergy Clin Immunol 102: 697-8 Addressing the controversy: do bisphosphonates directly affect primary tumors? Sterling JA (2015) Cancer Discov 5: 14-5 Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. Ohba T, Cole HA, Cates JM, Slosky DA, Haro H, Ando T, Schwartz HS, Schoenecker JG (2014) J Bone Miner Res 29: 1431-45 Racial differences in pain during 1 year among women with metastatic breast cancer: a hazards analysis of interval-censored data. Castel LD, Saville BR, Depuy V, Godley PA, Hartmann KE, Abernethy AP (2008) Cancer 112: 162-70 Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells. Zhuang J, Zhang J, Lwin ST, Edwards JR, Edwards CM, Mundy GR, Yang X (2012) PLoS One 7: e48871 Prostate cancer and bone metastases: medical treatment. Clark PE, Torti FM (2003) Clin Orthop Relat Res : S148-57 Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate. Bonnick SL, Silverman S, Tanner SB, Martens M, Bachmann G, Kohles JD, Civitelli R (2009) J Womens Health (Larchmt) 18: 935-43 Quality of life with advanced metastatic prostate cancer. Resnick MJ, Penson DF (2012) Urol Clin North Am 39: 505-15
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.